• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前M2BPGi评分可预测腹腔镜肝切除术中的手术难度及术后并发症的发生率。

The preoperative M2BPGi score predicts operative difficulty and the incidence of postoperative complications in laparoscopic liver resection.

作者信息

Fuji Tomokazu, Kojima Toru, Kajioka Hiroki, Sakamoto Misaki, Oka Ryoya, Katayama Tetsuya, Narahara Yuki, Niguma Takefumi

机构信息

Department of Surgery, Okayama Saiseikai General Hospital, 2-25 Kokutaicho, Kita-ku, Okayama, 700-8511, Japan.

出版信息

Surg Endosc. 2023 Feb;37(2):1262-1273. doi: 10.1007/s00464-022-09664-2. Epub 2022 Sep 29.

DOI:10.1007/s00464-022-09664-2
PMID:36175698
Abstract

BACKGROUND

Liver fibrosis or cirrhosis frequently makes parenchymal transection more difficult, but the difficulty score of laparoscopic liver resection (LLR), including the IWATE criteria, does not include a factor related to liver fibrosis. Therefore, this study aimed to evaluate M2BPGi as a predictor of the difficulty of parenchymal transection and the incidence of postoperative complications in LLR.

METHODS

Data from 54 patients who underwent laparoscopic partial liver resection (LLR-P) and 24 patients who underwent laparoscopic anatomical liver resection between 2017 and 2019 in our institution were retrospectively analyzed. All cases were classified according to M2BPGi scores, and reserve liver function, intraoperative blood loss, and postoperative complications were compared among these groups.

RESULTS

Sixteen cases (29.6%) were M2BPGi negative (cut-off index < 1.0), 25 cases (46.3%) were 1+ (1.0 ≤ cut-off index < 3.0), and 13 cases (24.1%) were 2+ (cut-off index ≥ 3.0). M2BPGi-positive cases had significantly worse hepatic reserve function (K-ICG: 0.16 vs 0.14 vs 0.08, p < 0.0001). Intraoperative bleeding was significantly greater in M2BPGi-positive cases [50 ml vs 150 ml vs 200 ml, M2BPGi (-) or (1+) vs M2BPGi (2+), p = 0.045]. Postoperative complications (Clavien-Dindo ≥ II) were significantly more frequent in M2BPGi-positive cases [0% vs 4% vs 33%, M2BPGi (-) or (1+) vs M2BPGi (2+), p = 0.001].

CONCLUSION

M2BPGi could predict surgical difficulty and complications in LLR-P. In particular, it might be better not to select M2BPGi (2+) cases as teaching cases because of the massive bleeding during parenchymal transection.

摘要

背景

肝纤维化或肝硬化常常使实质离断更加困难,但包括岩手标准在内的腹腔镜肝切除术(LLR)难度评分并未纳入与肝纤维化相关的因素。因此,本研究旨在评估M2BPGi作为LLR实质离断难度及术后并发症发生率预测指标的价值。

方法

回顾性分析2017年至2019年在本机构接受腹腔镜肝部分切除术(LLR-P)的54例患者及接受腹腔镜解剖性肝切除术的24例患者的数据。所有病例根据M2BPGi评分进行分类,并比较这些组之间的残余肝功能、术中出血量及术后并发症情况。

结果

16例(29.6%)为M2BPGi阴性(截断指数<1.0),25例(46.3%)为1+(1.0≤截断指数<3.0),13例(24.1%)为2+(截断指数≥3.0)。M2BPGi阳性病例的肝脏储备功能明显更差(吲哚氰绿滞留率:0.16对0.14对0.08,p<0.0001)。M2BPGi阳性病例的术中出血量明显更多[50ml对150ml对200ml,M2BPGi(-)或(1+)对M2BPGi(2+),p = 0.045]。M2BPGi阳性病例术后并发症(Clavien-Dindo≥Ⅱ级)明显更常见[0%对4%对33%,M2BPGi(-)或(1+)对M2BPGi(2+),p = 0.001]。

结论

M2BPGi可预测LLR-P的手术难度及并发症。特别是,由于实质离断时大量出血,可能最好不要选择M2BPGi(2+)病例作为教学病例。

相似文献

1
The preoperative M2BPGi score predicts operative difficulty and the incidence of postoperative complications in laparoscopic liver resection.术前M2BPGi评分可预测腹腔镜肝切除术中的手术难度及术后并发症的发生率。
Surg Endosc. 2023 Feb;37(2):1262-1273. doi: 10.1007/s00464-022-09664-2. Epub 2022 Sep 29.
2
Laparoscopic versus open limited liver resection for hepatocellular carcinoma with liver cirrhosis: a propensity score matching study with the Hiroshima Surgical study group of Clinical Oncology (HiSCO).腹腔镜与开腹局限性肝切除术治疗肝硬化肝细胞癌的比较:来自广岛临床肿瘤外科学会(HiSCO)的倾向评分匹配研究。
Surg Endosc. 2020 Nov;34(11):5055-5061. doi: 10.1007/s00464-019-07302-y. Epub 2019 Dec 11.
3
Resection type is a predictor of postoperative complications in laparoscopic partial liver resection.切除类型是腹腔镜部分肝切除术后并发症的预测因素。
Surg Endosc. 2022 Dec;36(12):9054-9063. doi: 10.1007/s00464-022-09372-x. Epub 2022 Jul 13.
4
Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma: A Case Controlled Study with Propensity Score Matching.腹腔镜与开腹肝切除术治疗肝细胞癌:一项倾向评分匹配的病例对照研究。
World J Surg. 2021 Aug;45(8):2572-2580. doi: 10.1007/s00268-021-06115-2. Epub 2021 Apr 21.
5
External validation of different difficulty scoring systems of laparoscopic liver resection for hepatocellular carcinoma.不同腹腔镜肝切除术困难评分系统用于肝细胞癌的外部验证。
Surg Endosc. 2022 Jun;36(6):3732-3749. doi: 10.1007/s00464-021-08687-5. Epub 2021 Aug 18.
6
Minor laparoscopic liver resection for Hepatocellular Carcinoma is safer than minor open resection, especially for less compensated cirrhotic patients: Propensity score analysis.肝细胞癌的小范围腹腔镜肝切除术比小范围开放性肝切除术更安全,尤其对于肝功能代偿较差的肝硬化患者:倾向评分分析
Surg Oncol. 2018 Dec;27(4):722-729. doi: 10.1016/j.suronc.2018.10.001. Epub 2018 Oct 3.
7
Validation of the IWATE criteria as a laparoscopic liver resection difficulty score in a single North American cohort.在北美一个单一队列中验证岩手县标准作为腹腔镜肝切除难度评分的有效性。
Surg Endosc. 2022 May;36(5):3601-3609. doi: 10.1007/s00464-021-08561-4. Epub 2021 May 24.
8
Laparoscopic liver resection: initial experience in a North-African single center.腹腔镜肝切除术:北非单中心的初步经验
Tunis Med. 2015 Aug-Sep;93(8-9):523-6.
9
Laparoscopic vs. open liver resection for hepatocellular carcinoma of cirrhotic liver: a case-control study.腹腔镜与开腹肝切除术治疗肝硬化性肝癌:一项病例对照研究
World J Surg. 2014 Nov;38(11):2919-26. doi: 10.1007/s00268-014-2659-z.
10
Feasibility and efficacy of repeat laparoscopic liver resection for recurrent hepatocellular carcinoma.重复腹腔镜肝切除术治疗复发性肝细胞癌的可行性和疗效。
Surg Endosc. 2020 Oct;34(10):4574-4581. doi: 10.1007/s00464-019-07246-3. Epub 2019 Dec 18.

引用本文的文献

1
Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert review.Mac-2结合蛋白糖基化异构体作为预测肝纤维化、活性及肝细胞癌发生的优秀生物标志物的效用:一项专家综述
J Gastroenterol. 2025 Jan;60(1):10-23. doi: 10.1007/s00535-024-02179-8. Epub 2024 Dec 9.

本文引用的文献

1
Study: International Multicentric Minimally Invasive Liver Resection for Colorectal Liver Metastases (SIMMILR-CRLM).研究:国际多中心微创肝切除术治疗结直肠癌肝转移(SIMMILR-CRLM)
Cancers (Basel). 2022 Mar 8;14(6):1379. doi: 10.3390/cancers14061379.
2
Three-Device (3D) Technique for Liver Parenchyma Dissection in Robotic Liver Surgery.机器人肝脏手术中肝实质离断的三器械(3D)技术
J Clin Med. 2021 Nov 12;10(22):5265. doi: 10.3390/jcm10225265.
3
Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study.
腹腔镜与开腹肝切除术治疗伴有 Child-Pugh B 级肝硬化的肝细胞癌:多中心倾向评分匹配研究。
Br J Surg. 2021 Mar 12;108(2):196-204. doi: 10.1093/bjs/znaa041.
4
The initiation, standardization and proficiency (ISP) phases of the learning curve for minimally invasive liver resection: comparison of a fellowship-trained surgeon with the pioneers and early adopters.微创肝切除术学习曲线的起始、标准化和熟练(ISP)阶段: fellowship 培训外科医生与先驱和早期采用者的比较。
Surg Endosc. 2021 Sep;35(9):5268-5278. doi: 10.1007/s00464-020-08122-1. Epub 2020 Nov 10.
5
Impact of liver cirrhosis on the difficulty of minimally-invasive liver resections: a 1:1 coarsened exact-matched controlled study.肝硬化对微创肝切除术难度的影响:1:1 粗糙精确匹配对照研究。
Surg Endosc. 2021 Sep;35(9):5231-5238. doi: 10.1007/s00464-020-08018-0. Epub 2020 Sep 24.
6
Post-Treatment M2BPGi Level and the Rate of Autotaxin Reduction are Predictive of Hepatocellular Carcinoma Development after Antiviral Therapy in Patients with Chronic Hepatitis C.治疗后 M2BPGi 水平和自分泌酶减少率可预测慢性丙型肝炎患者抗病毒治疗后肝细胞癌的发生。
Int J Mol Sci. 2020 Jun 25;21(12):4517. doi: 10.3390/ijms21124517.
7
Safe Dissemination of Laparoscopic Liver Resection in 27,146 Cases Between 2011 and 2017 From the National Clinical Database of Japan.2011 年至 2017 年日本国家临床数据库 27146 例腹腔镜肝切除术的安全传播。
Ann Surg. 2021 Dec 1;274(6):1043-1050. doi: 10.1097/SLA.0000000000003799.
8
On-treatment Serum Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) Level and Risk of Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B during Nucleot(s)ide Analogue Therapy.核苷(酸)类似物治疗期间慢性乙型肝炎患者治疗中血清 Mac-2 结合蛋白糖基化异构体(M2BPGi)水平与肝细胞癌发展风险的关系。
Int J Mol Sci. 2020 Mar 17;21(6):2051. doi: 10.3390/ijms21062051.
9
Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi.新型乙型肝炎和肝细胞癌生物标志物:HBcrAg 和 M2BPGi 的临床意义。
Int J Mol Sci. 2020 Jan 31;21(3):949. doi: 10.3390/ijms21030949.
10
Impact of cirrhosis in patients undergoing laparoscopic liver resection in a nationwide multicentre survey.全国多中心调查中肝硬化对腹腔镜肝切除术患者的影响。
Br J Surg. 2020 Feb;107(3):268-277. doi: 10.1002/bjs.11406. Epub 2020 Jan 9.